# Smith Midland Corp: financial statements, quarterly

SMID · Nasdaq · CIK 924719 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/smid.md) · [Financials](/companies/smid/financials.md) · [Filings](/companies/smid/filings.md) · [Insiders](/companies/smid/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/smid/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.7](/filings/0001654954-24-014461.md) | [16.4 d](/filings/0001654954-25-006144.md) | [16.8](/filings/0001654954-25-007941.md) | [19.6](/filings/0001654954-25-009560.md) | [23.6](/filings/0001654954-25-013097.md) | [18.5 d](/filings/0001654954-26-003505.md) | [22.7](/filings/0001654954-26-005829.md) | [26.2](/filings/0001654954-26-007660.md) | [21.5](/filings/0001654954-25-013097.md) | [23.1 d](/filings/0001654954-26-003505.md) | [21.6](/filings/0001654954-26-005829.md) | [23.4](/filings/0001654954-26-007660.md) |
| Cost of revenue | $m | [12.1](/filings/0001654954-24-014461.md) | [13.3 d](/filings/0001654954-25-006144.md) | [12.8](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [17.0](/filings/0001654954-25-013097.md) | [14.1 d](/filings/0001654954-26-003505.md) | [15.7](/filings/0001654954-26-005829.md) | [18.4](/filings/0001654954-26-007660.md) | [15.7](/filings/0001654954-25-013097.md) | [17.6 d](/filings/0001654954-26-003505.md) | [17.3](/filings/0001654954-26-005829.md) | [17.9](/filings/0001654954-26-007660.md) |
| Gross profit | $m | [3.6](/filings/0001654954-24-014461.md) | [3.1 d](/filings/0001654954-25-006144.md) | [3.9](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [6.6](/filings/0001654954-25-013097.md) | [4.4 d](/filings/0001654954-26-003505.md) | [7.0](/filings/0001654954-26-005829.md) | [7.8](/filings/0001654954-26-007660.md) | [5.8](/filings/0001654954-25-013097.md) | [5.5 d](/filings/0001654954-26-003505.md) | [4.3](/filings/0001654954-26-005829.md) | [5.4](/filings/0001654954-26-007660.md) |
| Operating income | $m | [1.5](/filings/0001654954-24-014461.md) | [0.5 d](/filings/0001654954-25-006144.md) | [1.5](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [3.8](/filings/0001654954-25-013097.md) | [1.9 d](/filings/0001654954-26-003505.md) | [4.4](/filings/0001654954-26-005829.md) | [5.5](/filings/0001654954-26-007660.md) | [3.9](/filings/0001654954-25-013097.md) | [3.2 d](/filings/0001654954-26-003505.md) | [1.7](/filings/0001654954-26-005829.md) | [2.0](/filings/0001654954-26-007660.md) |
| Interest expense | $m | [0.1](/filings/0001654954-24-014461.md) | [0.1 d](/filings/0001654954-25-006144.md) | [0.1](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [0.1](/filings/0001654954-25-013097.md) | [0.1 d](/filings/0001654954-26-003505.md) | [0.1](/filings/0001654954-26-005829.md) | [0.1](/filings/0001654954-26-007660.md) | [0.0](/filings/0001654954-25-013097.md) | [0.1 d](/filings/0001654954-26-003505.md) | [0.0](/filings/0001654954-26-005829.md) | [0.1](/filings/0001654954-26-007660.md) |
| Income tax | $m | [0.2](/filings/0001654954-24-014461.md) | [0.4 d](/filings/0001654954-25-006144.md) | [0.4](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [0.7](/filings/0001654954-25-013097.md) | [0.5 d](/filings/0001654954-26-003505.md) | [1.0](/filings/0001654954-26-005829.md) | [1.3](/filings/0001654954-26-007660.md) | [1.0](/filings/0001654954-25-013097.md) | [1.2 d](/filings/0001654954-26-003505.md) | [0.4](/filings/0001654954-26-005829.md) | [0.4](/filings/0001654954-26-007660.md) |
| Net income | $m | [1.3](/filings/0001654954-24-014461.md) | [0.2 d](/filings/0001654954-25-006144.md) | [1.1](/filings/0001654954-25-013097.md) | [2.0](/filings/0001654954-25-013097.md) | [3.2](/filings/0001654954-25-013097.md) | [1.4 d](/filings/0001654954-26-003505.md) | [3.3](/filings/0001654954-26-007660.md) | [4.2](/filings/0001654954-26-007660.md) | [2.9](/filings/0001654954-25-013097.md) | [2.1 d](/filings/0001654954-26-003505.md) | [1.3](/filings/0001654954-26-007660.md) | [1.4](/filings/0001654954-26-007660.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.21](/filings/0001654954-25-007941.md) | [0.37](/filings/0001654954-25-009560.md) | [0.59](/filings/0001654954-25-013097.md) | not reported | [0.62](/filings/0001654954-26-005829.md) | [0.79](/filings/0001654954-26-007660.md) | [0.54](/filings/0001654954-25-013097.md) | not reported | [0.25](/filings/0001654954-26-005829.md) | [0.26](/filings/0001654954-26-007660.md) |
| Basic EPS | $ per share | [0.24](/filings/0001654954-24-014461.md) | not reported | [0.22](/filings/0001654954-25-007941.md) | [0.37](/filings/0001654954-25-009560.md) | [0.59](/filings/0001654954-25-013097.md) | not reported | [0.63](/filings/0001654954-26-005829.md) | [0.79](/filings/0001654954-26-007660.md) | [0.54](/filings/0001654954-25-013097.md) | not reported | [0.25](/filings/0001654954-26-005829.md) | [0.26](/filings/0001654954-26-007660.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.8](/filings/0001654954-23-013966.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [29.9](/filings/0001654954-23-013966.md) | [33.3](/filings/0001654954-25-006144.md) | [35.7](/filings/0001654954-24-007614.md) | [33.7](/filings/0001654954-24-010647.md) | [35.0](/filings/0001654954-24-014461.md) | [35.8](/filings/0001654954-26-003505.md) | [41.6](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [49.8](/filings/0001654954-25-013097.md) | [48.7](/filings/0001654954-26-007660.md) | [51.6](/filings/0001654954-26-005829.md) | [46.1](/filings/0001654954-26-007660.md) |
| Total assets | $m | [57.7](/filings/0001654954-23-013966.md) | [61.3](/filings/0001654954-25-006144.md) | [64.9](/filings/0001654954-24-007614.md) | [64.0](/filings/0001654954-24-010647.md) | [66.6](/filings/0001654954-24-014461.md) | [68.0](/filings/0001654954-26-003505.md) | [74.7](/filings/0001654954-25-007941.md) | [0.1](/filings/0001654954-25-009560.md) | [85.4](/filings/0001654954-25-013097.md) | [87.7](/filings/0001654954-26-007660.md) | [92.2](/filings/0001654954-26-005829.md) | [86.7](/filings/0001654954-26-007660.md) |
| Current liabilities | $m | [12.9](/filings/0001654954-23-013966.md) | [16.0](/filings/0001654954-25-006144.md) | [17.4](/filings/0001654954-24-007614.md) | [14.9](/filings/0001654954-24-010647.md) | [12.6](/filings/0001654954-24-014461.md) | [15.0](/filings/0001654954-26-003505.md) | [17.3](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [18.0](/filings/0001654954-25-013097.md) | [14.3](/filings/0001654954-26-007660.md) | [16.6](/filings/0001654954-26-005829.md) | [11.4](/filings/0001654954-26-007660.md) |
| Total liabilities | $m | [23.8](/filings/0001654954-23-013966.md) | [27.2](/filings/0001654954-25-006144.md) | [29.5](/filings/0001654954-24-007614.md) | [26.9](/filings/0001654954-24-010647.md) | [26.3](/filings/0001654954-24-014461.md) | [26.3](/filings/0001654954-26-003505.md) | [29.6](/filings/0001654954-25-007941.md) | [0.0](/filings/0001654954-25-009560.md) | [33.3](/filings/0001654954-25-013097.md) | [33.4](/filings/0001654954-26-007660.md) | [36.5](/filings/0001654954-26-005829.md) | [29.7](/filings/0001654954-26-007660.md) |
| Shareholders' equity | $m | [33.8](/filings/0001654954-24-014461.md) | [34.2](/filings/0001654954-26-003505.md) | [35.3](/filings/0001654954-25-013097.md) | [37.2](/filings/0001654954-25-013097.md) | [40.3](/filings/0001654954-25-013097.md) | [41.7](/filings/0001654954-26-007660.md) | [45.1](/filings/0001654954-26-007660.md) | [49.2](/filings/0001654954-26-007660.md) | [52.1](/filings/0001654954-25-013097.md) | [54.3](/filings/0001654954-26-007660.md) | [55.7](/filings/0001654954-26-007660.md) | [57.0](/filings/0001654954-26-007660.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-23) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-23) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.4 d](/filings/0001654954-24-014461.md) | [4.3 d](/filings/0001654954-25-006144.md) | [(0.8)](/filings/0001654954-25-007941.md) | [0.8 d](/filings/0001654954-25-009560.md) | [5.8 d](/filings/0001654954-25-013097.md) | [(0.6) d](/filings/0001654954-26-003505.md) | [2.2](/filings/0001654954-26-005829.md) | [(2.2) d](/filings/0001654954-25-009560.md) | [11.7 d](/filings/0001654954-25-013097.md) | [2.6 d](/filings/0001654954-26-003505.md) | [3.1](/filings/0001654954-26-005829.md) | [(0.5) d](/filings/0001654954-26-007660.md) |
| Capital expenditure | $m | [1.2 d](/filings/0001654954-24-014461.md) | [0.9 d](/filings/0001654954-25-006144.md) | [1.8](/filings/0001654954-25-007941.md) | [(1.8) d](/filings/0001654954-25-009560.md) | [5.5 d](/filings/0001654954-25-013097.md) | [0.7 d](/filings/0001654954-26-003505.md) | [0.6](/filings/0001654954-26-005829.md) | [(0.6) d](/filings/0001654954-25-009560.md) | [5.4 d](/filings/0001654954-25-013097.md) | [4.0 d](/filings/0001654954-26-003505.md) | [1.6](/filings/0001654954-26-005829.md) | [1.9 d](/filings/0001654954-26-007660.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,286](/filings/0001654954-23-013966.md) | [5,290](/filings/0001654954-24-007614.md) | [5.3](/filings/0001654954-24-010647.md) | [5,298](/filings/0001654954-24-014461.md) | [5,350](/filings/0001654954-25-007941.md) | [5,323](/filings/0001654954-25-009560.md) | [5.3](/filings/0001654954-25-013097.md) | [5,305](/filings/0001654954-26-005829.md) | [5,305](/filings/0001654954-26-007660.md) | [5.3](/filings/0001654954-25-013097.md) | [5,307](/filings/0001654954-26-005829.md) | [5,307](/filings/0001654954-26-007660.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,304,606 at 2026-08-01, from the cover of the [10-Q filed 2026-08-14](/filings/0001654954-26-007660.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.